Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

v3.24.1.1.u2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating expenses    
Research and development $ 1,946,450 $ 1,184,880
General and administrative 4,205,800 1,915,278
Total operating expenses 6,152,250 3,100,158
Operating loss (6,152,250) (3,100,158)
Other (income) expense    
Interest expense 436,936 18,396
Interest income (426,514) (24,514)
(Gain) loss from asset sales (1,145,141) 307,086
Debt conversion inducement expense 0 1,383,285
Wind-down costs 0 383,109
Total other (income) expense, net (1,134,719) 2,067,362
Loss before income taxes (5,017,531) (5,167,520)
Provision for income taxes 2,000 0
Net loss $ (5,019,531) $ (5,167,520)
Loss per common share:    
Basic (in dollars per share) $ (0.18) $ (1.37)
Diluted (in dollars per share) $ (0.18) $ (1.37)
Weighted average shares of common stock outstanding used to compute earnings per share:    
Basic (in shares) 27,999,901 3,767,578
Diluted (in shares) 27,999,901 3,767,578